IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Reviva Pharmaceutcls Hldgs I

CUSIP: 76152G950 | 4 institutional holders

Quarters

Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile